Barcelona 2022

---

Holistic management and rehabilitation of fibrosing interstitial lung diseases

Symposium
Chairs: A. Dinh-Xuan (Paris, France), H. Pinnock (Edinburgh (Edinburgh), United Kingdom)
Aims: to describe progress in non-pharmacological management of patients with fibrosing interstitial lung diseases (f-ILDs), including changes in clinical practice and the efficacy of treatments, using a patient-centred approach; to analyse the importance of self-management and the growing role of information and computing technologies in supporting monitoring, rehabilitation and non-pharmacological interventions in f-ILDs, including after lung transplantation; to describe non-pharmacological interventions that aim to relieve symptoms and improve quality of life; to provide an update on dedicated pulmonary rehabilitation strategies and outcome measures in f-ILDs, considering the "new normal" in the context of the pandemic; to discuss new insights into the role of oxygen supplementation in management of breathlessness and the role of ambulatory oxygen in preventing exertional hypoxaemia and maximising the benefits of pulmonary rehabilitation.

Patient's testimony S. Jones (Cambridge, United Kingdom)
Digitally supported self-management and rehabilitation of f-ILD patients M. Wijsenbeek (Rotterdam, Netherlands)
Supportive care pathways for patients with f-ILDs and the impact of the COVID-19 pandemic E. Renzoni (London, United Kingdom)
Standards of pulmonary rehabilitation in f-ILDs: where are we? A. Holland (Fitzroy North (VIC), Australia)
The role of oxygen in the management of dyspnoea in f-ILDs M. Ekström (Lund, Sweden)
Discussion and Q&A